Hadassah

Hadassah University Medical Center Clinical Trial Reveals Success of New Treatment Combination for Post-Traumatic Stress Disorder

Monday, Sep 12 2011

Results of a clinical trial at the Hadassah University Medical Center indicate that Deep Transcranial Magnetic Stimulation (TMS) can be an effective treatment for Post-Traumatic Stress Disorder (PTSD) when combined with exposure to trauma memory cues.

TMS is a noninvasive procedure that uses magnetic fields to stimulate nerve cells in the brain. "This study," relates Principal Investigator Dr. Moshe Isseries of Hadassah's Department of Psychiatry, "was the first of its kind designed to test the effectiveness of TMS on people with severe or resistant PTSD." Only a few studies, he says, "have been conducted using magnetic stimulation and none using the combination of magnetic stimulation and exposure to trauma memory."

The trial involved an innovative device, developed by the Israeli company, Brainsway Ltd, which stimulates extensive areas deeper in the cortex. The 26 patients in the trial were divided into three groups: One group was treated using the Deep TMS device together with a brief exposure to trauma cues (reminders of a traumatic event conveyed to the patient through earphones); a second group received Deep TMS treatment with no trauma cues; and a third group received sham stimulation with exposure to trauma cues. All the patients in the study participated in at least 8 sessions, the minimum required for treatment.
Only the group that received active Deep TMS with exposure to cues showed a statistically significant improvement. "There was a marked decrease in nightmares and flashbacks and improvement in sleeping, mood, and functioning," Dr. Isseries reports. Follow-up questionnaires yielded similar findings. The improvement remained constant.

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Tuesday, Apr 17 2018

Where are we with Stem Cells? Hadassah Pioneer Brings Us Up to Date

Many diseases involve the malfunctioning or dying of cells within the body.

READ MORE ›
alt_text

Tuesday, Apr 17 2018

Predicting Clinical Outcomes for Multiple Sclerosis Patients: Cutting-Edge Research at Hadassah

More than two million people--two to three times more women--have multiple sclerosis (MS)--the leading cause of neurological disability among young adults. What is their prognosis?

READ MORE ›
alt_text

Friday, Apr 13 2018

Hadassah Hospital Mount Scopus Hosts Conference to Mark Annual World Down Syndrome Day

Hadassah Hospital Mount Scopus hosted 200 people at the annual World Down Syndrome Day conference, held at the hospital in late March.

READ MORE ›
alt_text

Friday, Apr 13 2018

Hadassah Physicians Increase Number of Partial Thyroidectomies Following New ATA Guidelines

Following updated recommendations from the American Thyroid Association (ATA), Nir Hirschoren, M.D., of the Hadassah-Hebrew University Medical Center in Jerusalem...

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More